Astrana Health [ASTH] vs National Healthcare [NHC] Detailed Stock Comparison
Astrana Health
NASDAQ
Loading...
National Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Astrana Health wins in 2 metrics, National Healthcare wins in 17 metrics, with 0 ties. National Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health | National Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 55.29 | 18.11 | National Healthcare |
| Price-to-Book Ratio | 1.85 | 1.84 | National Healthcare |
| Debt-to-Equity Ratio | 83.20 | 16.83 | National Healthcare |
| PEG Ratio | -1.05 | -1.50 | National Healthcare |
| EV/EBITDA | 13.24 | 11.20 | National Healthcare |
| Profit Margin (TTM) | 1.04% | 7.19% | National Healthcare |
| Operating Margin (TTM) | 3.11% | 9.09% | National Healthcare |
| EBITDA Margin (TTM) | 3.11% | 9.09% | National Healthcare |
| Return on Equity | 5.44% | 10.66% | National Healthcare |
| Return on Assets (TTM) | 3.25% | 5.02% | National Healthcare |
| Free Cash Flow (TTM) | $44.17M | $79.70M | National Healthcare |
| Dividend Yield | N/A | 2.30% | N/A |
| 1-Year Return | -48.66% | -1.63% | National Healthcare |
| Price-to-Sales Ratio (TTM) | 0.55 | 1.29 | Astrana Health |
| Enterprise Value | $1.31B | $1.80B | National Healthcare |
| EV/Revenue Ratio | 0.54 | 1.23 | Astrana Health |
| Gross Profit Margin (TTM) | 11.91% | 39.58% | National Healthcare |
| Revenue per Share (TTM) | $50 | $94 | National Healthcare |
| Earnings per Share (Diluted) | $0.52 | $6.70 | National Healthcare |
| Beta (Stock Volatility) | 0.81 | 0.59 | National Healthcare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Astrana Health vs National Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health | 0.42% | -0.38% | -2.17% | 19.54% | -1.43% | -10.34% |
| National Healthcare | -2.37% | -3.29% | 2.17% | 13.63% | 30.92% | 11.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health | -48.66% | -8.35% | 57.93% | 340.76% | 466.08% | 466.08% |
| National Healthcare | -1.63% | 93.47% | 86.28% | 83.43% | 222.72% | 233.26% |
News Based Sentiment: Astrana Health vs National Healthcare
Astrana Health
News based Sentiment: POSITIVE
Astrana Health reported strong financial performance with significant revenue and EPS growth, coupled with a very positive analyst outlook and a substantial potential upside. This combination of factors makes it a noteworthy development for investors.
National Healthcare
News based Sentiment: MIXED
October saw significant institutional investment in NHC, which is a positive sign, but this was counterbalanced by a lease default notice and mixed stock performance. The dividend provides stability, but the overall picture is complex, making it a moderately important month for investors.
Performance & Financial Health Analysis: Astrana Health vs National Healthcare
| Metric | ASTH | NHC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.39B | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 324,610 | 76,840 |
| 90 Day Avg. Volume | 348,273 | 73,717 |
| Last Close | $28.87 | $118.44 |
| 52 Week Range | $21.20 - $63.20 | $89.14 - $136.86 |
| % from 52W High | -54.32% | -13.46% |
| All-Time High | $133.23 (Nov 15, 2021) | $138.49 (Jul 29, 2024) |
| % from All-Time High | -78.33% | -14.48% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.35% | 0.29% |
| Quarterly Earnings Growth | -0.51% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.07% |
| Operating Margin (TTM) | 0.03% | 0.09% |
| Return on Equity (TTM) | 0.05% | 0.11% |
| Debt to Equity (MRQ) | 83.20 | 16.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.58 | $65.93 |
| Cash per Share (MRQ) | $6.85 | $16.62 |
| Operating Cash Flow (TTM) | $130.56M | $149.07M |
| Levered Free Cash Flow (TTM) | $97.63M | $100.15M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.30% |
| Last 12-Month Dividend | N/A | $2.44 |
Valuation & Enterprise Metrics Analysis: Astrana Health vs National Healthcare
| Metric | ASTH | NHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 55.29 | 18.11 |
| Forward P/E | 18.79 | 282.14 |
| PEG Ratio | -1.05 | -1.50 |
| Price to Sales (TTM) | 0.55 | 1.29 |
| Price to Book (MRQ) | 1.85 | 1.84 |
| Market Capitalization | ||
| Market Capitalization | $1.39B | $1.91B |
| Enterprise Value | $1.31B | $1.80B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.54 | 1.23 |
| Enterprise to EBITDA | 13.24 | 11.20 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 0.59 |
| Book Value per Share (MRQ) | $15.58 | $65.93 |
Financial Statements Comparison: Astrana Health vs National Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASTH | NHC |
|---|---|---|
| Revenue/Sales | $654.81M | $373.70M |
| Cost of Goods Sold | $576.84M | $228.13M |
| Gross Profit | $77.97M | $145.57M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $20.34M | $30.77M |
| EBITDA | $31.10M | $43.87M |
| Pre-Tax Income | $16.83M | $43.72M |
| Income Tax | $6.61M | $11.43M |
| Net Income (Profit) | $10.22M | $32.29M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASTH | NHC |
|---|---|---|
| Cash & Equivalents | $258.52M | $90.39M |
| Total Current Assets | $613.27M | $455.20M |
| Total Current Liabilities | $361.27M | $239.23M |
| Long-Term Debt | $433.40M | $163.31M |
| Total Shareholders Equity | $517.71M | $1.01B |
| Retained Earnings | $292.88M | $774.95M |
| Property, Plant & Equipment | $47.55M | $1.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASTH | NHC |
|---|---|---|
| Operating Cash Flow | $12.67M | $47.95M |
| Capital Expenditures | $-3.07M | $-6.14M |
| Free Cash Flow | $13.56M | $33.12M |
| Debt Repayment | $-428.38M | $-3.00M |
| Common Stock Repurchase | $-1.32M | $-1.72M |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | NHC |
|---|---|---|
| Shares Short | 1.55M | 259,597 |
| Short Ratio | 4.49 | 6.59 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 324,610 | 76,840 |
| Average Daily Volume (90 Day) | 348,273 | 73,717 |
| Shares Outstanding | 47.93M | 15.45M |
| Float Shares | 37.56M | 12.46M |
| % Held by Insiders | 0.22% | 0.19% |
| % Held by Institutions | 0.53% | 0.59% |
Dividend Analysis & Yield Comparison: Astrana Health vs National Healthcare
| Metric | ASTH | NHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.44 |
| Last 12-Month Dividend Yield | N/A | 2.30% |
| 3-Year Avg Annual Dividend | N/A | $2.36 |
| 3-Year Avg Dividend Yield | N/A | 0.75% |
| 3-Year Total Dividends | N/A | $7.08 |
| Ex-Dividend Date | N/A | Mar 28, 2025 |